3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
7
Unknown
2
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Colorectal Neoplasms
3
Skin Neoplasms
2
Melanoma
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Turcot syndrome
1
Solid Tumors
1
Solid Tumor, Adult
1
Rectal Neoplasms
1
Radiation Pneumonitis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Motor Activity
1
Lung Neoplasms
1
Locally Advanced Esophageal Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Interventions
Cisplatin
11
Gemcitabine
10
Radiotherapy, Intensity-Modulated
6
Capecitabine
6
Drug Therapy
3
Docetaxel
3
toripalimab
2
spartalizumab
2
pembrolizumab
2
nimotuzumab
2
fludarabine
2
atezolizumab
2
Specimen Handling
2
Platinum
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
Cyclophosphamide
2
Carboplatin
2
Bevacizumab
2
1,2-diaminocyclohexaneplatinum II citrate
2
tislelizumab
1
sintilimab
1
penpulimab
1
olaparib
1
fludarabine phosphate
1
dehydroftorafur
1
camrelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Nasopharyngeal Carcinoma
×
Immune Checkpoint Inhibitors
×
Clear all
NCT04907370
2025-07-16
DIAMOND
Sun Yat-sen University
Phase 3
Active not recruiting
532 enrolled